Elizabeth Bohlen serves as Executive at Insys Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Elizabeth Bohlen has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 4, 2019 involved receiving (via award) 8,083 shares valued at $0.
Elizabeth Bohlen currently holds 14,083 shares of Insys Therapeutics, Inc. (INSY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Elizabeth Bohlen has been a net neutral trader of INSY stock. They have purchased $0 and sold $0 worth of shares.
Elizabeth Bohlen's most recent insider trade was on Mar 4, 2019, when they sold 8,083 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Aug 7, 2018 | INSY | $0 | Award | 6,000 | $N/A | Discretionary |